SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Abiomed Inc – ‘10-Q’ for 12/31/19 – ‘EX-101.SCH’

On:  Thursday, 2/6/20, at 4:07pm ET   ·   For:  12/31/19   ·   Accession #:  1564590-20-3682   ·   File #:  1-09585

Previous ‘10-Q’:  ‘10-Q’ on 10/31/19 for 9/30/19   ·   Next:  ‘10-Q’ on 8/6/20 for 6/30/20   ·   Latest:  ‘10-Q’ on 11/3/22 for 9/30/22

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/06/20  Abiomed Inc                       10-Q       12/31/19   85:13M                                    ActiveDisclosure/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.29M 
 2: EX-3.2.1    Articles of Incorporation/Organization or Bylaws    HTML    181K 
 3: EX-3.2.2    Articles of Incorporation/Organization or Bylaws    HTML    204K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
79: R1          Document and Entity Information                     HTML     78K 
32: R2          Condensed Consolidated Balance Sheets               HTML    122K 
22: R3          Condensed Consolidated Balance Sheets               HTML     47K 
                (Parenthetical)                                                  
55: R4          Condensed Consolidated Statements of Operations     HTML     82K 
78: R5          Condensed Consolidated Statements of Comprehensive  HTML     49K 
                Income                                                           
31: R6          Condensed Consolidated Statements of Stockholders'  HTML    124K 
                Equity                                                           
21: R7          Condensed Consolidated Statements of Cash Flows     HTML    123K 
54: R8          Nature of Business                                  HTML     29K 
80: R9          Basis of Preparation and Summary of Significant     HTML     34K 
                Accounting Policies                                              
58: R10         Net Income Per Share                                HTML    127K 
81: R11         Revenue Recognition                                 HTML    127K 
40: R12         Financial Instruments                               HTML    504K 
29: R13         Property and Equipment                              HTML     63K 
59: R14         Goodwill, In-Process Research and Development and   HTML    139K 
                Other Assets                                                     
82: R15         Leases                                              HTML     94K 
41: R16         Accrued Expenses                                    HTML     59K 
30: R17         Stockholders' Equity                                HTML    165K 
57: R18         Stock-Based Compensation                            HTML    215K 
83: R19         Income Taxes                                        HTML    104K 
42: R20         Commitments and Contingencies                       HTML     45K 
14: R21         Segment and Enterprise Wide Disclosures             HTML     29K 
62: R22         Basis of Preparation and Summary of Significant     HTML    112K 
                Accounting Policies (Policies)                                   
69: R23         Net Income Per Share (Tables)                       HTML    125K 
43: R24         Revenue Recognition (Tables)                        HTML     92K 
15: R25         Financial Instruments (Tables)                      HTML    506K 
63: R26         Property and Equipment (Tables)                     HTML     63K 
70: R27         Goodwill, In-Process Research and Development and   HTML    138K 
                Other Assets (Tables)                                            
44: R28         Leases (Tables)                                     HTML     91K 
12: R29         Accrued Expenses (Tables)                           HTML     58K 
27: R30         Stockholders' Equity (Tables)                       HTML    166K 
39: R31         Stock-Based Compensation (Tables)                   HTML    220K 
85: R32         Income Taxes (Tables)                               HTML     99K 
61: R33         Computation of Basic and Diluted Net Income Per     HTML     54K 
                Share (Detail)                                                   
26: R34         Net Income Per Share - Additional Information       HTML     28K 
                (Detail)                                                         
38: R35         Revenue Recognition - Schedule of Categorizes       HTML     37K 
                Revenue by Major Business Line (Detail)                          
84: R36         Revenue Recognition - Terms - Additional            HTML     39K 
                Information (Detail)                                             
60: R37         Revenue Recognition - Deferred Revenue -            HTML     30K 
                Additional Information (Detail)                                  
28: R38         Cash Equivalents and Marketable Securities          HTML     34K 
                (Detail)                                                         
37: R39         Investable Cash Equivalents and Marketable          HTML     60K 
                Securities (Detail)                                              
19: R40         Financial Instruments - Additional Information      HTML     44K 
                (Detail)                                                         
50: R41         Schedule of Cross-Currency Rate Swap Derivatives    HTML     35K 
                (Detail)                                                         
72: R42         Schedule of Fair Value of Company's Derivative      HTML     29K 
                Instrument (Detail)                                              
65: R43         Financial Instruments Measured at Fair Value        HTML     75K 
                (Detail)                                                         
18: R44         Valuation Method Used to Calculate Level 3          HTML     73K 
                Liabilities Measured at Estimated Fair Value of                  
                Contingent Consideration Related to Acquisition                  
                (Detail)                                                         
49: R45         Change in Fair Value of Contingent Consideration    HTML     40K 
                as Determined by Level 3 Inputs (Detail)                         
71: R46         Components of Property and Equipment (Detail)       HTML     50K 
64: R47         Goodwill, In-Process Research and Development and   HTML     70K 
                Other Assets - Additional Information (Detail)                   
20: R48         Carrying Value of Goodwill and Change in Balance    HTML     30K 
                (Detail)                                                         
48: R49         Carrying value of In-Process Research and           HTML     29K 
                Development (Detail)                                             
33: R50         Summary of Other Assets (Detail)                    HTML     34K 
24: R51         Equity Method and Other Investments Classified as   HTML     34K 
                Other Assets (Detail)                                            
51: R52         Carrying value of Equity Method and Other           HTML     34K 
                Investments (Detail)                                             
76: R53         Supplemental Balance Sheet Information Related to   HTML     33K 
                Operating Leases (Detail)                                        
34: R54         Leases - Additional Information (Details)           HTML     30K 
25: R55         Maturities of Operating Lease Liabilities           HTML     49K 
                (Details)                                                        
53: R56         Minimum Future Lease Payments (Detail)              HTML     45K 
77: R57         Accrued Expenses (Detail)                           HTML     46K 
36: R58         Stockholders' Equity - Additional Information       HTML     37K 
                (Detail)                                                         
23: R59         Stockholders' Equity - Schedule of Share            HTML     35K 
                Repurchase Activity (Detail)                                     
67: R60         Stockholders' Equity - Schedule of Accumulated      HTML     49K 
                Other Comprehensive Income (Loss) (Detail)                       
73: R61         Stock-Based Compensation Recognized (Detail)        HTML     35K 
46: R62         Summary of Stock Option Activity (Detail)           HTML     80K 
16: R63         Stock-Based Compensation - Additional Information   HTML     56K 
                (Detail)                                                         
68: R64         Summary of Weighted Average Grant-Date Fair Values  HTML     40K 
                And Weighted Average Assumptions Used to Calculate               
                Fair Value of Options Granted (Detail)                           
74: R65         Summary of Restricted Stock Units Activity          HTML     50K 
                (Detail)                                                         
47: R66         Income Taxes - Additional Information (Detail)      HTML     34K 
17: R67         Differences Between Statutory Income Tax Rate and   HTML     49K 
                Effective Income Tax Rate (Detail)                               
66: R68         Commitments and Contingencies - Additional          HTML     31K 
                Information (Detail)                                             
75: R69         Segment and Enterprise Wide Disclosures -           HTML     40K 
                Additional Information (Detail)                                  
13: XML         IDEA XML File -- Filing Summary                      XML    155K 
45: XML         XBRL Instance -- abmd-10q_20191231_htm               XML   3.85M 
35: EXCEL       IDEA Workbook of Financial Reports                  XLSX     87K 
 8: EX-101.CAL  XBRL Calculations -- abmd-20191231_cal               XML    199K 
 9: EX-101.DEF  XBRL Definitions -- abmd-20191231_def                XML    414K 
10: EX-101.LAB  XBRL Labels -- abmd-20191231_lab                     XML   1.15M 
11: EX-101.PRE  XBRL Presentations -- abmd-20191231_pre              XML    904K 
 7: EX-101.SCH  XBRL Schema -- abmd-20191231                         XSD    156K 
56: JSON        XBRL Instance as JSON Data -- MetaLinks              322±   521K 
52: ZIP         XBRL Zipped Folder -- 0001564590-20-003682-xbrl      Zip    273K

‘EX-101.SCH’   —   XBRL Schema — abmd-20191231

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date : 2020-02-05T16:45:05.6391600+00:00 -->
<!-- Version : 5.0.1.321 -->
<!-- Package ID : bc057c33f0664df7b42520cdd810000d -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:abmd="http://www.abiomed.com/20191231" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2019-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.abiomed.com/20191231" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" namespace="http://xbrl.sec.gov/country/2017-01-31"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2019-01-31"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31"/>
<xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric"/>
<xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2019-01-31"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" namespace="http://xbrl.sec.gov/invest/2013-01-31"/>
<xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact"/>
<xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated"/>
<xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31"/>
<xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" namespace="http://fasb.org/srt/2019-01-31"/>
<xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd" namespace="http://fasb.org/srt-roles/2019-01-31"/>
<xsd:import schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" namespace="http://fasb.org/srt-types/2019-01-31"/>
<xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31"/>
<xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" namespace="http://fasb.org/us-gaap/2019-01-31"/>
<xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd" namespace="http://fasb.org/us-roles/2019-01-31"/>
<xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" namespace="http://fasb.org/us-types/2019-01-31"/>
<xsd:annotation>
<xsd:appinfo>
<link:roleType id="TemplateLink" roleURI="http://www.abiomed.com/20191231/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
<link:definition> 00000 - Document - Template Link </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abmd-20191231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation Links, all" xlink:type="simple" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abmd-20191231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abmd-20191231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="abmd-20191231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple"/>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
<link:definition> 100000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" id="Role_StatementCondensedConsolidatedBalanceSheets">
<link:definition> 100010 - Statement - Condensed Consolidated Balance Sheets </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="Role_StatementCondensedConsolidatedBalanceSheetsParenthetical">
<link:definition> 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperations" id="Role_StatementCondensedConsolidatedStatementsOfOperations">
<link:definition> 100030 - Statement - Condensed Consolidated Statements of Operations </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncome" id="Role_StatementCondensedConsolidatedStatementsOfComprehensiveIncome">
<link:definition> 100040 - Statement - Condensed Consolidated Statements of Comprehensive Income </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity" id="Role_StatementCondensedConsolidatedStatementsOfStockholdersEquity">
<link:definition> 100050 - Statement - Condensed Consolidated Statements of Stockholders' Equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="Role_StatementCondensedConsolidatedStatementsOfCashFlows">
<link:definition> 100060 - Statement - Condensed Consolidated Statements of Cash Flows </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureNatureOfBusiness" id="Role_DisclosureNatureOfBusiness">
<link:definition> 100070 - Disclosure - Nature of Business </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPolicies" id="Role_DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPolicies">
<link:definition> 100080 - Disclosure - Basis of Preparation and Summary of Significant Accounting Policies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureNetIncomePerShare" id="Role_DisclosureNetIncomePerShare">
<link:definition> 100090 - Disclosure - Net Income Per Share </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureRevenueRecognition" id="Role_DisclosureRevenueRecognition">
<link:definition> 100100 - Disclosure - Revenue Recognition </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureFinancialInstruments" id="Role_DisclosureFinancialInstruments">
<link:definition> 100110 - Disclosure - Financial Instruments </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
<link:definition> 100120 - Disclosure - Property and Equipment </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssets" id="Role_DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssets">
<link:definition> 100130 - Disclosure - Goodwill, In-Process Research and Development and Other Assets </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureLeases" id="Role_DisclosureLeases">
<link:definition> 100140 - Disclosure - Leases </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureAccruedExpenses" id="Role_DisclosureAccruedExpenses">
<link:definition> 100150 - Disclosure - Accrued Expenses </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
<link:definition> 100160 - Disclosure - Stockholders' Equity </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
<link:definition> 100170 - Disclosure - Stock-Based Compensation </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
<link:definition> 100180 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
<link:definition> 100190 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSegmentAndEnterpriseWideDisclosures" id="Role_DisclosureSegmentAndEnterpriseWideDisclosures">
<link:definition> 100200 - Disclosure - Segment and Enterprise Wide Disclosures </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureBasisOfPreparationAndSummaryOfSignificantAccountingPoliciesPolicies">
<link:definition> 100210 - Disclosure - Basis of Preparation and Summary of Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureNetIncomePerShareTables" id="Role_DisclosureNetIncomePerShareTables">
<link:definition> 100220 - Disclosure - Net Income Per Share (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureRevenueRecognitionTables" id="Role_DisclosureRevenueRecognitionTables">
<link:definition> 100230 - Disclosure - Revenue Recognition (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureFinancialInstrumentsTables" id="Role_DisclosureFinancialInstrumentsTables">
<link:definition> 100240 - Disclosure - Financial Instruments (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
<link:definition> 100250 - Disclosure - Property and Equipment (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssetsTables" id="Role_DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssetsTables">
<link:definition> 100260 - Disclosure - Goodwill, In-Process Research and Development and Other Assets (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
<link:definition> 100270 - Disclosure - Leases (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureAccruedExpensesTables" id="Role_DisclosureAccruedExpensesTables">
<link:definition> 100280 - Disclosure - Accrued Expenses (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
<link:definition> 100290 - Disclosure - Stockholders' Equity (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
<link:definition> 100300 - Disclosure - Stock-Based Compensation (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
<link:definition> 100310 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureComputationOfBasicAndDilutedNetIncomePerShareDetail" id="Role_DisclosureComputationOfBasicAndDilutedNetIncomePerShareDetail">
<link:definition> 100320 - Disclosure - Computation of Basic and Diluted Net Income Per Share (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureNetIncomePerShareAdditionalInformationDetail" id="Role_DisclosureNetIncomePerShareAdditionalInformationDetail">
<link:definition> 100330 - Disclosure - Net Income Per Share - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureRevenueRecognitionScheduleOfCategorizesRevenueByMajorBusinessLineDetail" id="Role_DisclosureRevenueRecognitionScheduleOfCategorizesRevenueByMajorBusinessLineDetail">
<link:definition> 100340 - Disclosure - Revenue Recognition - Schedule of Categorizes Revenue by Major Business Line (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureRevenueRecognitionTermsAdditionalInformationDetail" id="Role_DisclosureRevenueRecognitionTermsAdditionalInformationDetail">
<link:definition> 100350 - Disclosure - Revenue Recognition - Terms - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureRevenueRecognitionDeferredRevenueAdditionalInformationDetail" id="Role_DisclosureRevenueRecognitionDeferredRevenueAdditionalInformationDetail">
<link:definition> 100360 - Disclosure - Revenue Recognition - Deferred Revenue - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureCashEquivalentsAndMarketableSecuritiesDetail" id="Role_DisclosureCashEquivalentsAndMarketableSecuritiesDetail">
<link:definition> 100370 - Disclosure - Cash Equivalents and Marketable Securities (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureInvestableCashEquivalentsAndMarketableSecuritiesDetail" id="Role_DisclosureInvestableCashEquivalentsAndMarketableSecuritiesDetail">
<link:definition> 100380 - Disclosure - Investable Cash Equivalents and Marketable Securities (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetail" id="Role_DisclosureFinancialInstrumentsAdditionalInformationDetail">
<link:definition> 100390 - Disclosure - Financial Instruments - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureScheduleOfCrossCurrencyRateSwapDerivativesDetail" id="Role_DisclosureScheduleOfCrossCurrencyRateSwapDerivativesDetail">
<link:definition> 100400 - Disclosure - Schedule of Cross-Currency Rate Swap Derivatives (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureScheduleOfFairValueOfCompanySDerivativeInstrumentDetail" id="Role_DisclosureScheduleOfFairValueOfCompanySDerivativeInstrumentDetail">
<link:definition> 100410 - Disclosure - Schedule of Fair Value of Company's Derivative Instrument (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureFinancialInstrumentsMeasuredAtFairValueDetail" id="Role_DisclosureFinancialInstrumentsMeasuredAtFairValueDetail">
<link:definition> 100420 - Disclosure - Financial Instruments Measured at Fair Value (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureValuationMethodUsedToCalculateLevel3LiabilitiesMeasuredAtEstimatedFairValueOfContingentConsiderationRelatedToAcquisitionDetail" id="Role_DisclosureValuationMethodUsedToCalculateLevel3LiabilitiesMeasuredAtEstimatedFairValueOfContingentConsiderationRelatedToAcquisitionDetail">
<link:definition> 100430 - Disclosure - Valuation Method Used to Calculate Level 3 Liabilities Measured at Estimated Fair Value of Contingent Consideration Related to Acquisition (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureChangeInFairValueOfContingentConsiderationAsDeterminedByLevel3InputsDetail" id="Role_DisclosureChangeInFairValueOfContingentConsiderationAsDeterminedByLevel3InputsDetail">
<link:definition> 100440 - Disclosure - Change in Fair Value of Contingent Consideration as Determined by Level 3 Inputs (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureComponentsOfPropertyAndEquipmentDetail" id="Role_DisclosureComponentsOfPropertyAndEquipmentDetail">
<link:definition> 100450 - Disclosure - Components of Property and Equipment (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssetsAdditionalInformationDetail" id="Role_DisclosureGoodwillInProcessResearchAndDevelopmentAndOtherAssetsAdditionalInformationDetail">
<link:definition> 100460 - Disclosure - Goodwill, In-Process Research and Development and Other Assets - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureCarryingValueOfGoodwillAndChangeInBalanceDetail" id="Role_DisclosureCarryingValueOfGoodwillAndChangeInBalanceDetail">
<link:definition> 100470 - Disclosure - Carrying Value of Goodwill and Change in Balance (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureCarryingValueOfInProcessResearchAndDevelopmentDetail" id="Role_DisclosureCarryingValueOfInProcessResearchAndDevelopmentDetail">
<link:definition> 100480 - Disclosure - Carrying value of In-Process Research and Development (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSummaryOfOtherAssetsDetail" id="Role_DisclosureSummaryOfOtherAssetsDetail">
<link:definition> 100490 - Disclosure - Summary of Other Assets (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureEquityMethodAndOtherInvestmentsClassifiedAsOtherAssetsDetail" id="Role_DisclosureEquityMethodAndOtherInvestmentsClassifiedAsOtherAssetsDetail">
<link:definition> 100500 - Disclosure - Equity Method and Other Investments Classified as Other Assets (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureCarryingValueOfEquityMethodAndOtherInvestmentsDetail" id="Role_DisclosureCarryingValueOfEquityMethodAndOtherInvestmentsDetail">
<link:definition> 100510 - Disclosure - Carrying value of Equity Method and Other Investments (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSupplementalBalanceSheetInformationRelatedToOperatingLeasesDetail" id="Role_DisclosureSupplementalBalanceSheetInformationRelatedToOperatingLeasesDetail">
<link:definition> 100520 - Disclosure - Supplemental Balance Sheet Information Related to Operating Leases (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="Role_DisclosureLeasesAdditionalInformationDetails">
<link:definition> 100530 - Disclosure - Leases - Additional Information (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureMaturitiesOfOperatingLeaseLiabilitiesDetails" id="Role_DisclosureMaturitiesOfOperatingLeaseLiabilitiesDetails">
<link:definition> 100540 - Disclosure - Maturities of Operating Lease Liabilities (Details) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureMaturitiesOfOperatingLeaseLiabilitiesDetails2" id="Role_DisclosureMaturitiesOfOperatingLeaseLiabilitiesDetails2">
<link:definition> 100550 - Disclosure - Maturities of Operating Lease Liabilities (Details)2 </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureMinimumFutureLeasePaymentsDetail" id="Role_DisclosureMinimumFutureLeasePaymentsDetail">
<link:definition> 100560 - Disclosure - Minimum Future Lease Payments (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureAccruedExpensesDetail" id="Role_DisclosureAccruedExpensesDetail">
<link:definition> 100570 - Disclosure - Accrued Expenses (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail" id="Role_DisclosureStockholdersEquityAdditionalInformationDetail">
<link:definition> 100580 - Disclosure - Stockholders' Equity - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockholdersEquityScheduleOfShareRepurchaseActivityDetail" id="Role_DisclosureStockholdersEquityScheduleOfShareRepurchaseActivityDetail">
<link:definition> 100590 - Disclosure - Stockholders' Equity - Schedule of Share Repurchase Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail" id="Role_DisclosureStockholdersEquityScheduleOfAccumulatedOtherComprehensiveIncomeLossDetail">
<link:definition> 100600 - Disclosure - Stockholders' Equity - Schedule of Accumulated Other Comprehensive Income (Loss) (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockBasedCompensationRecognizedDetail" id="Role_DisclosureStockBasedCompensationRecognizedDetail">
<link:definition> 100610 - Disclosure - Stock-Based Compensation Recognized (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSummaryOfStockOptionActivityDetail" id="Role_DisclosureSummaryOfStockOptionActivityDetail">
<link:definition> 100620 - Disclosure - Summary of Stock Option Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetail">
<link:definition> 100630 - Disclosure - Stock-Based Compensation - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSummaryOfWeightedAverageGrantDateFairValuesAndWeightedAverageAssumptionsUsedToCalculateFairValueOfOptionsGrantedDetail" id="Role_DisclosureSummaryOfWeightedAverageGrantDateFairValuesAndWeightedAverageAssumptionsUsedToCalculateFairValueOfOptionsGrantedDetail">
<link:definition> 100640 - Disclosure - Summary of Weighted Average Grant-Date Fair Values And Weighted Average Assumptions Used to Calculate Fair Value of Options Granted (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSummaryOfRestrictedStockUnitsActivityDetail" id="Role_DisclosureSummaryOfRestrictedStockUnitsActivityDetail">
<link:definition> 100650 - Disclosure - Summary of Restricted Stock Units Activity (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" id="Role_DisclosureIncomeTaxesAdditionalInformationDetail">
<link:definition> 100660 - Disclosure - Income Taxes - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureDifferencesBetweenStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateDetail" id="Role_DisclosureDifferencesBetweenStatutoryIncomeTaxRateAndEffectiveIncomeTaxRateDetail">
<link:definition> 100670 - Disclosure - Differences Between Statutory Income Tax Rate and Effective Income Tax Rate (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetail">
<link:definition> 100680 - Disclosure - Commitments and Contingencies - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.abiomed.com/20191231/taxonomy/role/DisclosureSegmentAndEnterpriseWideDisclosuresAdditionalInformationDetail" id="Role_DisclosureSegmentAndEnterpriseWideDisclosuresAdditionalInformationDetail">
<link:definition> 100690 - Disclosure - Segment and Enterprise Wide Disclosures - Additional Information (Detail) </link:definition>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element id="abmd_StockIssuedToDirectorsValue" name="StockIssuedToDirectorsValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="abmd_StockIssuedToDirectorsShares" name="StockIssuedToDirectorsShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_ProceedsFromSaleAndMaturityOfMarketableSecuritiesAndOther" name="ProceedsFromSaleAndMaturityOfMarketableSecuritiesAndOther" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="abmd_PaymentsToAcquireOtherInvestmentsAndIntangibleAssets" name="PaymentsToAcquireOtherInvestmentsAndIntangibleAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="abmd_RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" name="RightOfUseAssetsObtainedInExchangeForLeaseLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="abmd_GoodwillInProcessResearchAndDevelopmentAndOtherAssetsTextBlock" name="GoodwillInProcessResearchAndDevelopmentAndOtherAssetsTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_NewAccountingPronouncementsAdoptedPolicyPolicyTextBlock" name="NewAccountingPronouncementsAdoptedPolicyPolicyTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_CashEquivalentsAndMarketableSecuritiesTableTextBlock" name="CashEquivalentsAndMarketableSecuritiesTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_ScheduleOfEquityMethodAndOtherInvestmentsTableTextBlock" name="ScheduleOfEquityMethodAndOtherInvestmentsTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_ScheduleOfPortfolioOfEquityMethodAndOtherInvestmentsAndChangeInBalanceTableTextBlock" name="ScheduleOfPortfolioOfEquityMethodAndOtherInvestmentsAndChangeInBalanceTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" name="ScheduleOfSupplementalBalanceSheetInformationTableTextBlock" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_ImpellaProductMember" name="ImpellaProductMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ServiceAndOtherMember" name="ServiceAndOtherMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_PerformanceObligationsMaximumTerm" name="PerformanceObligationsMaximumTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationPaymentPeriod" name="ContractWithCustomerTimingOfSatisfactionOfPerformanceObligationPaymentPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_LongTermInvestmentsMember" name="LongTermInvestmentsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_LoansToSubsidiaries" name="LoansToSubsidiaries" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="abmd_IntercompanyAgreementMember" name="IntercompanyAgreementMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_EcpEntwicklungsgesellschaftMbHAndAisGmbhAachenInnovativeSolutionsMember" name="EcpEntwicklungsgesellschaftMbHAndAisGmbhAachenInnovativeSolutionsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ShockwaveMedicalMember" name="ShockwaveMedicalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_MilestonePayment" name="MilestonePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="abmd_EcpEntwickslungsgesellschaftMbhMember" name="EcpEntwickslungsgesellschaftMbhMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_MonteCarloSimulationModelMember" name="MonteCarloSimulationModelMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ClinicalAndRegulatoryMilestoneMember" name="ClinicalAndRegulatoryMilestoneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_RevenueBasedMilestoneMember" name="RevenueBasedMilestoneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ProbabilityAdjustmentLevelAxis" name="ProbabilityAdjustmentLevelAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ProbabilityAdjustmentLevelDomain" name="ProbabilityAdjustmentLevelDomain" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_VariousMember" name="VariousMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_BaseCaseScenarioMember" name="BaseCaseScenarioMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ContingentConsiderationMember" name="ContingentConsiderationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_FairValueInputsYearOfPayments" name="FairValueInputsYearOfPayments" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_FairValueInputsProbabilityOfOccurrence" name="FairValueInputsProbabilityOfOccurrence" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_FairValueInputsProbabilityOfPaymentUnderRiskNeutral" name="FairValueInputsProbabilityOfPaymentUnderRiskNeutral" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_MedicalDeviceCompaniesMember" name="MedicalDeviceCompaniesMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_LicenseManufacturingRightsToTechnologyMember" name="LicenseManufacturingRightsToTechnologyMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_IndefiniteLivedIntangibleAssetsAccumulatedImpairmentLoss" name="IndefiniteLivedIntangibleAssetsAccumulatedImpairmentLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="abmd_EquityMethodAndOtherInvestments" name="EquityMethodAndOtherInvestments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="abmd_OtherIntangibleAssetsAndOtherAssets" name="OtherIntangibleAssetsAndOtherAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
<xsd:element id="abmd_AccruedResearchAndDevelopmentExpenseCurrent" name="AccruedResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
<xsd:element id="abmd_AccruedExpensesAbstract" name="AccruedExpensesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ShareholdersEquityLineItems" name="ShareholdersEquityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ShareholdersEquityTable" name="ShareholdersEquityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_PerformanceBasedRestrictedStockUnitsMember" name="PerformanceBasedRestrictedStockUnitsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_ValuationAssumptionsAbstract" name="ValuationAssumptionsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_EffectiveIncomeTaxRateReconciliationExcessTaxBenefitShareBasedCompensationCost" name="EffectiveIncomeTaxRateReconciliationExcessTaxBenefitShareBasedCompensationCost" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_EffectiveIncomeTaxRateReconciliationPermanentDifferences" name="EffectiveIncomeTaxRateReconciliationPermanentDifferences" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_PatentExpirationPeriod" name="PatentExpirationPeriod" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
<xsd:element id="abmd_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_PatentOneMember" name="PatentOneMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_PatentTwoMember" name="PatentTwoMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_PatentThreeMember" name="PatentThreeMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
<xsd:element id="abmd_InternationalMember" name="InternationalMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>

↑Top
Filing Submission 0001564590-20-003682   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 1:25:49.1pm ET